Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Other Working Capital history
Currency unavailable · from the cash flow
No Other Working Capital data reported for this period type.
Other Working Capital vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $80.48M USD | +252.0% | +19.7% | 7.1% | |
| LTM Mar 2026 | $72.73M USD | +119.8% | +91.8% | 20.2% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 48.33M SEK | +89.2% | — | 3634.1% |
| LTM Mar 2026 | $3.27M USD | +161.9% | -75.2% | 2.8% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +140.8% | +19.7% | 13.6% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.